Alternative Therapies, Incentive Models Eyed For Antibiotic Resistance 28/03/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment As bacteria become more and more resistant to existing medicines, product pipelines are drying up. A solution may lie in a forgotten therapy developed in 1917, the use of which has been restricted to certain parts of Eastern Europe ever since the discovery and universal use of antibiotics. But business models and intellectual property regimes need to change to provide incentives for research and development in this area.
WHO Members Discuss Engagement With Non-State Actors This Week 27/03/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization this week is holding an information consultation with member states on the UN agency’s engagement with “non-state actors.” The meeting follows a request by member states at the January WHO Executive Board to pursue discussions on a framework for the organisation’s engagement with non-state actors, which has been changing in recent years.
US Corporate IP Counsel Hear Latest Updates On Patent System 24/03/2014 by William New, Intellectual Property Watch Leave a Comment NEW YORK – “This is a very, very exciting time be in patent law,” Drew Hirshfeld, deputy commissioner for patent examination policy at the US Patent and Trademark Office, told a group of intellectual property lawyers last week. In his keynote address to the 19-20 March Corporate IP Counsel meeting in Manhattan, Hirshfeld and a range of private sector speakers laid out a picture of a highly dynamic field, with legal and business opportunities and challenges changing every day.
Analysis Shows Mixed Results On Big Pharma R&D Efforts For TB 24/03/2014 by Intellectual Property Watch Leave a Comment In time for World TB Day today, an analysis has been published of research and development being carried out for tuberculosis by the 20 largest pharmaceutical companies.
WIPO Design Treaty Fate Left To Assembly, Despite Shift On Technical Assistance 21/03/2014 by Catherine Saez, Intellectual Property Watch 1 Comment The World Intellectual Property Organization committee on trademarks could not agree this week to recommend the convening of a high-level meeting to adopt a treaty on industrial designs.
New Document On Technical Assistance, But WIPO Design Treaty Still In Trouble 20/03/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment World Intellectual Property Organization delegates are trying to find a way out of a dividing line on how to address technical assistance in a potential new treaty on industrial designs. A new non-paper by the chair of the WIPO Standing Committee on the Law of Trademarks, Industrial Designs and Geographical indications (SCT) was released this morning. At stake is the committee’s recommendation on the convening of a high level meeting to agree on the treaty.
European Patent Office Staff Calls Strike; President Battistelli Reacts 19/03/2014 by Dugie Standeford for Intellectual Property Watch 3 Comments European Patent Office (EPO) employees on 13 March approved seven office-wide strike days, starting on 21 March. The move follows an increasingly tense stand-off between the Staff Union of the European Patent Office (SUEPO) and President Benoît Battistelli over, as a union document put it, timely access to justice, freedom of speech and freedom of association. The deteriorating relationship between employees and office officials prompted one French lawmaker to ask government ministers to rethink their country’s support for Battistelli’s reappointment. If unresolved, the labour issues could end up subjecting the EPO to closer scrutiny as it prepares to administer the EU unitary patent, one source close to the situation said.
Interview With Hans Hogerzeil: Recognising Good Practices Of Pharma 18/03/2014 by Julia Fraser for Intellectual Property Watch 1 Comment The issue of medicines access for low-income people in developing countries has been of major concern to global health policymakers for years. A key issue is the inability of northern pharmaceutical producers to develop and distribute affordable medicines and recover their research and development costs. As part of the effort to address this, a non-governmental group was formed in coordination with industry and other stakeholders to develop an index to rate companies’ efforts to ameliorate the situation. Julia Fraser for Intellectual Property Watch recently sat down with Hans Hogerzeil, a former senior World Health Organization official and a top strategist for the Access to Medicine Index, to discuss the index’s impact, independence and the future.
Breeders’ Group CIOPORA Redefining Its Position On IP 17/03/2014 by Intellectual Property Watch 2 Comments The International Community of breeders of asexually reproduced ornamental and fruit plants (CIOPORA) is preparing a new position on intellectual property rights to respond to changes in the market and what it says is the need for greater protection for breeders.
How To Safeguard Trade Secrets: Think ROI 17/03/2014 by Intellectual Property Watch Leave a Comment Amid intensifying competition in the global economy, companies rely more heavily than ever on the advantages of trade secrets. This critical proprietary information includes, for example, market research, product plans, unique formulas and manufacturing methods, computer code and customer data – knowledge that companies build through years of hard work, experience and investment, writes Pamela Passman.